Vice President, Head of Clinical Operations

Role Description

Your work will change lives. Including your own.

At Recursion, we are decoding biology to radically improve lives. As Vice President, Head of Clinical Operations, you will own clinical operations strategy and execution across Recursion’s development portfolio from study planning through study closeout, data delivery, inspection readiness, and registrational support.

This is a portfolio-wide leadership role for an experienced clinical operations leader who can:

• Build scalable operating models
• Lead high-performing teams
• Manage global trials
• Ensure operational excellence across early and late-stage clinical programs

You will also help define what modern clinical operations look like in an AI-native TechBio company:

• Data-driven
• Quality-focused
• Patient-centered
• Technology-enabled
• Built to move with urgency because patients are waiting

In this role, you will:

• Lead clinical operations strategy and execution across Recursion’s full clinical portfolio, from IND/CTA planning and first-in-human studies through proof-of-concept, pivotal trials, study closeout, and submission support
• Own end-to-end operational delivery, including study planning, feasibility, country and site strategy, start-up, enrollment, monitoring, vendor oversight, budget management, database lock readiness, and closeout
• Build, scale, and mentor a high-performing Clinical Operations organization, including clinical project management, clinical trial management, outsourcing/vendor oversight, and portfolio operations capabilities
• Establish portfolio-level governance, operating rhythms, KPIs, dashboards, risk management, resource planning, and escalation pathways to support timely, high-quality trial execution
• Lead CRO and vendor strategy relationships, including outsourcing model, selection, contracting partnership, performance management, issue escalation, budget forecasting, and accountability for delivery
• Ensure inspection-ready execution across all studies through strong GCP compliance, SOP adherence, TMF oversight, risk-based quality management, audit readiness, CAPA management, and proactive issue resolution

Qualifications

• Bachelor’s degree in a scientific, healthcare, or related field required; advanced degree preferred
• 15+ years of biotech or pharmaceutical clinical operations experience, including significant leadership experience overseeing multiple clinical programs and global clinical trials
• Proven track record leading clinical operations from early development through pivotal studies, registration-enabling trials, study closeout, and submission support
• Deep experience with clinical trial planning and execution, including feasibility, start-up, enrollment, monitoring, vendor/CRO oversight, budget management, risk management, database lock, and closeout
• Strong working knowledge of FDA, EMA, MHRA, ICH/GCP, global clinical trial regulations, quality systems, inspection readiness, and risk-based quality management
• Experience building and leading teams, including leaders of clinical operations, clinical project managers, clinical trial managers, consultants, CRO partners, and functional vendors
• Strong executive presence with the ability to communicate clearly, influence senior stakeholders, resolve complex operational issues, and drive decisions in a fast-moving environment
• Experience in oncology, rare disease, and/or specialty clinical development preferred; experience with clinical trial technologies, CTMS/eTMF/EDC/IRT/eCOA, operational dashboards, automation, or AI-enabled workflows is a plus

Requirements

• This is a fully remote opportunity with occasional travel requirements.
• Travel may be necessary from time to time to support collaboration, team events, customer meetings, or other business needs.

Benefits

• Estimated annual base salary range for New York City, Boston, & San Francisco Bay Area(s): $333,000–$400,510
• Estimated annual base salary range for Salt Lake City & all other U.S. locations: $303,600–$364,100
• Eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

Company Description

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need.

Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London.